Nutriflex 40/80 G-E (Valine, Arginine Glutamate, Alanine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine)

Nutriflex 40/80 G-E provides a comprehensive amino acid profile for patients with increased metabolic demand. It is used in the following clinical situations:

• Critical illness: Helps maintain nitrogen balance and supports tissue repair.
• Post‑operative recovery: Contributes to protein synthesis during the healing phase.
• Severe malnutrition: Supplies essential amino acids when oral intake is insufficient.
• Trauma patients: Assists in rebuilding lean body mass after injury.
• Long‑term parenteral nutrition: Provides a stable source of amino acids for home or hospital‑based PN.
• Burn‑treatment care: Supports the high protein turnover required in extensive burn recovery.

• Nutriflex 40/80 G-E delivers a balanced mixture of essential and non‑essential amino acids directly into the bloodstream, bypassing gastrointestinal absorption. The amino acids serve as substrates for protein synthesis, stimulate insulin release, and help replenish nitrogen stores, thereby supporting tissue repair, immune function, and metabolic homeostasis in patients receiving parenteral nutrition.

Nutriflex 40/80 G-E is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Hyperglycaemia: Elevated blood‑sugar levels, especially in diabetic patients.
• Electrolyte imbalance: Shifts in potassium, sodium or calcium concentrations.
• Mild infusion‑site irritation: Redness or discomfort at the catheter site.
• Nausea: Transient feeling of queasiness during infusion.
• Headache: Low‑grade headache during or after administration.

Serious or Rare Side Effects

• Anaphylaxis: Acute, life‑threatening allergic reaction.
• Metabolic acidosis: Significant drop in blood pH.
• Hepatic dysfunction: Elevated liver enzymes indicating liver stress.
• Renal impairment: Worsening kidney function in susceptible individuals.
• Seizures: Rare neurologic events linked to electrolyte disturbances.

Nutriflex 40/80 G-E should be used with careful clinical monitoring.

• Renal function: Assess baseline kidney parameters before initiation.
• Hepatic function: Monitor liver enzymes during therapy.
• Blood glucose: Check glucose levels regularly, especially in diabetics.
• Electrolyte status: Observe serum electrolytes and correct abnormalities.
• Fluid balance: Adjust infusion rates to maintain appropriate volume status.
• Store at ambient temperature: keep  ");

• The amino‑acids  ");
• ---  
• --- 
• t
• "  " """  """ "" " """ " """ "" """ "" " "" "" 
• " "" 
• g 
• t
• ");